Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol in Never-Smoking Flight Attendants Exposed to Secondhand Smoke
NCT02797275Phase 4Active, not recruiting
- Sponsor
- University of California, San Francisco
- Start
- Jun 2016
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of albuterol dry powder inhaler in Obstructive Lung Disease (OLD), sponsored by University of California, San Francisco. Started Jun 2016; status: active, not recruiting.
02
Drugs
albuterol dry powder inhaler
03
Conditions
Obstructive Lung Disease (OLD)
Beyond the preview
Go deeper on NCT02797275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02797275.